FreshBurst Listerine protocol
This article was originally published in The Tan Sheet
Executive Summary
Pfizer proposes six-month, multi-center gingivitis study of 340 subjects at three clinical sites in Canada, Florida and Ohio for FreshBurst Listerine with Fluoride in Oct. 14 letter to FDA. Each center will have a principal investigator, who also may function as the site's clinical examiner. Pfizer originally had suggested a single-center study, which FDA opposed at an Aug. 27 feedback meeting (1"The Tan Sheet" Sept. 2, 2002, p. 14). Pfizer also agrees with FDA's suggestion to reduce the number of exclusion criteria. Pregnant women, diabetics, individuals with partial dentures or oral piercings are included under modified protocol, while those with "history of significant adverse events following use of oral hygiene products," "history of serious medical conditions" or alcoholism are excluded...
You may also be interested in...
FreshBurst Listerine protocol
FDA approves Pfizer's proposed six-month, multi-center, 340-person gingivitis study in recent letter, noting if the trial determines "Listerine with fluoride is as effective as Listerine in reducing gingivitis and plaque," agency likely will grant the sodium fluoride/essential oils combination monograph status. FDA says it "will explore regulatory mechanisms for interim marketing under the OTC drug monograph procedures at [that] time." Pfizer modified its study proposal in October after an FDA feedback meeting (1"The Tan Sheet" Nov. 18, 2002, In Brief)...
FreshBurst Listerine Study Must Exhibit 20% Gingivitis Reduction – FDA
A six-month study of FreshBurst Listerine with Fluoride will need to show "a 20% reduction in gingivitis" over the control to receive agency approval, FDA told Pfizer execs at an Aug. 27 meeting
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.